Jessica Kohring, MD
Foot and Ankle Surgery · Spokane, WANPI 1174865216
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (43.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Stryker accounts for 67.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $2,134 and has fallen 83.0% since, to $363 in 2025.
Across 58 payments — averaging $117.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Summit Surgical Corp.$1K
- Medical Device Business Services, Inc.$494
- Smith+Nephew$254
- Treace Medical Concepts, Inc.$171
- Paragon 28, Inc.$52
- plus $48 from 3 others
What the payments were for
- Travel & lodging$2,99144%
- Food & beverage$2,62439%
- Education$1,20018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 39 | $4,596 |
| Summit Surgical Corp. | 1 | $1,200 |
| Medical Device Business Services, Inc. | 5 | $494 |
| Smith+Nephew | 3 | $254 |
| Treace Medical Concepts, Inc. | 5 | $171 |
| Paragon 28, Inc. | 2 | $52 |
| Bioventus LLC | 1 | $24 |
| Arthrex | 1 | $19 |
| Fusion Orthopedics USA, LLC | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$1,426
- INBONE$680
- STAR$643
- PROstep$464
- INFINITY ADAPTIS$295
- AUGMENT INJECTABLE$173
- VLP-Foot$115
- VLP Mini-MOD$115
- TSF Ally$115
- Conquest FN$115
- TRIGEN InterTAN$107
- Lapiplasty System$106
How this compares
$6,815 in reported general payments places this provider in the 80th percentile of 203 foot and ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 31 | $655 |
| Oxycodone Hcl | 103 | $510 |
| Meloxicam | 57 | $339 |
| Pregabalin | 19 | $308 |
| Cephalexin | 17 | $277 |
| Ondansetron OdtOndansetron | 35 | $259 |
| Nitroglycerin PatchNitroglycerin | 12 | $217 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $144 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Spokane
- Kevin DowSpokane$20K
- Brady StewartSpokane$7K
- Kimberly SkallaSpokane$5K
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.